vs
Side-by-side financial comparison of FIRST MID BANCSHARES, INC. (FMBH) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $88.2M, roughly 1.7× FIRST MID BANCSHARES, INC.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs 7.8%, a 19.0% gap on every dollar of revenue. On growth, FIRST MID BANCSHARES, INC. posted the faster year-over-year revenue change (3.4% vs -41.1%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $69.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 5.0%).
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
FMBH vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $88.2M | $151.7M |
| Net Profit | $23.7M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | 34.0% | 20.4% |
| Net Margin | 26.8% | 7.8% |
| Revenue YoY | 3.4% | -41.1% |
| Net Profit YoY | 23.5% | -80.8% |
| EPS (diluted) | $0.98 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $88.2M | $151.7M | ||
| Q3 25 | $89.3M | $267.8M | ||
| Q2 25 | $87.5M | $244.0M | ||
| Q1 25 | $84.3M | $211.8M | ||
| Q4 24 | $85.3M | $257.6M | ||
| Q3 24 | $80.6M | $78.8M | ||
| Q2 24 | $79.2M | $76.1M | ||
| Q1 24 | $79.9M | $67.5M |
| Q4 25 | $23.7M | $11.8M | ||
| Q3 25 | $22.5M | $55.4M | ||
| Q2 25 | $23.4M | $-17.7M | ||
| Q1 25 | $22.2M | $21.2M | ||
| Q4 24 | $19.2M | $61.6M | ||
| Q3 24 | $19.5M | $-8.8M | ||
| Q2 24 | $19.7M | $-364.0K | ||
| Q1 24 | $20.5M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | 34.0% | 20.4% | ||
| Q3 25 | 32.2% | 48.7% | ||
| Q2 25 | 34.4% | 13.8% | ||
| Q1 25 | 33.4% | 38.1% | ||
| Q4 24 | 29.7% | 44.4% | ||
| Q3 24 | 31.5% | 12.3% | ||
| Q2 24 | 33.7% | 7.0% | ||
| Q1 24 | 33.7% | 2.1% |
| Q4 25 | 26.8% | 7.8% | ||
| Q3 25 | 25.2% | 20.7% | ||
| Q2 25 | 26.8% | -7.3% | ||
| Q1 25 | 26.3% | 10.0% | ||
| Q4 24 | 22.5% | 23.9% | ||
| Q3 24 | 24.2% | -11.2% | ||
| Q2 24 | 24.9% | -0.5% | ||
| Q1 24 | 25.6% | -0.5% |
| Q4 25 | $0.98 | $2.34 | ||
| Q3 25 | $0.94 | $7.76 | ||
| Q2 25 | $0.98 | $-2.95 | ||
| Q1 25 | $0.93 | $3.33 | ||
| Q4 24 | $0.81 | $11.56 | ||
| Q3 24 | $0.81 | $-1.72 | ||
| Q2 24 | $0.82 | $-0.07 | ||
| Q1 24 | $0.86 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $185.6M |
| Total DebtLower is stronger | $354.5M | — |
| Stockholders' EquityBook value | $958.7M | $329.4M |
| Total Assets | $8.0B | $918.5M |
| Debt / EquityLower = less leverage | 0.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | — | $96.7M | ||
| Q1 25 | — | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | — | $46.9M | ||
| Q2 24 | — | $40.8M | ||
| Q1 24 | — | $30.0M |
| Q4 25 | $354.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $958.7M | $329.4M | ||
| Q3 25 | $932.2M | $317.2M | ||
| Q2 25 | $894.1M | $235.3M | ||
| Q1 25 | $870.9M | $176.9M | ||
| Q4 24 | $846.4M | $132.4M | ||
| Q3 24 | $858.5M | $60.4M | ||
| Q2 24 | $813.6M | $62.7M | ||
| Q1 24 | $798.0M | $63.0M |
| Q4 25 | $8.0B | $918.5M | ||
| Q3 25 | $7.8B | $964.5M | ||
| Q2 25 | $7.7B | $841.0M | ||
| Q1 25 | $7.6B | $761.9M | ||
| Q4 24 | $7.5B | $655.3M | ||
| Q3 24 | $7.6B | $438.5M | ||
| Q2 24 | $7.6B | $422.4M | ||
| Q1 24 | $7.7B | $404.3M |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.9M | $70.4M |
| Free Cash FlowOCF − Capex | $124.0M | $69.0M |
| FCF MarginFCF / Revenue | 140.6% | 45.5% |
| Capex IntensityCapex / Revenue | 7.8% | 0.9% |
| Cash ConversionOCF / Net Profit | 5.53× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $207.9M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.9M | $70.4M | ||
| Q3 25 | $33.0M | $99.5M | ||
| Q2 25 | $7.7M | $27.3M | ||
| Q1 25 | $47.9M | $51.0M | ||
| Q4 24 | $124.4M | $54.0K | ||
| Q3 24 | $33.1M | $6.8M | ||
| Q2 24 | $24.0M | $13.3M | ||
| Q1 24 | $29.0M | $3.1M |
| Q4 25 | $124.0M | $69.0M | ||
| Q3 25 | $31.9M | $99.2M | ||
| Q2 25 | $6.0M | $26.5M | ||
| Q1 25 | $46.0M | $50.9M | ||
| Q4 24 | $119.5M | $-341.0K | ||
| Q3 24 | $32.0M | $6.2M | ||
| Q2 24 | $22.9M | $12.7M | ||
| Q1 24 | $27.6M | $2.3M |
| Q4 25 | 140.6% | 45.5% | ||
| Q3 25 | 35.8% | 37.0% | ||
| Q2 25 | 6.8% | 10.9% | ||
| Q1 25 | 54.5% | 24.0% | ||
| Q4 24 | 140.0% | -0.1% | ||
| Q3 24 | 39.7% | 7.8% | ||
| Q2 24 | 28.9% | 16.7% | ||
| Q1 24 | 34.5% | 3.4% |
| Q4 25 | 7.8% | 0.9% | ||
| Q3 25 | 1.2% | 0.1% | ||
| Q2 25 | 2.0% | 0.3% | ||
| Q1 25 | 2.3% | 0.0% | ||
| Q4 24 | 5.8% | 0.2% | ||
| Q3 24 | 1.4% | 0.8% | ||
| Q2 24 | 1.4% | 0.7% | ||
| Q1 24 | 1.9% | 1.1% |
| Q4 25 | 5.53× | 5.95× | ||
| Q3 25 | 1.47× | 1.80× | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 2.16× | 2.40× | ||
| Q4 24 | 6.49× | 0.00× | ||
| Q3 24 | 1.70× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMBH
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
